Screening and prostate-cancer mortality in a randomized European study.

• The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific-antigen (PSA) testing on death rates from prostate cancer.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Läkemedelskemi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Medicinal Chemistry (hsv//eng)

Keyword

Age Factors

Aged

Biopsy

Digital Rectal Examination

Europe

epidemiology

Follow-Up Studies

Humans

Male

Mass Screening

utilization

Middle Aged

Patient Compliance

Prostate

pathology

Prostate-Specific Antigen

blood

Prostatectomy

Prostatic Neoplasms

diagnosis

mortality

therapy

ultrasonography

Quality of Life

Registries

Regression Analysis

Risk

Publication and Content Type

vet (subject category)

art (subject category)